ES2141044B1 - OXIBUTININE THERAPY. - Google Patents
OXIBUTININE THERAPY.Info
- Publication number
- ES2141044B1 ES2141044B1 ES9800339A ES9800339A ES2141044B1 ES 2141044 B1 ES2141044 B1 ES 2141044B1 ES 9800339 A ES9800339 A ES 9800339A ES 9800339 A ES9800339 A ES 9800339A ES 2141044 B1 ES2141044 B1 ES 2141044B1
- Authority
- ES
- Spain
- Prior art keywords
- therapy
- oxibutinine
- oxybutynin
- composition
- administering
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Terapia con oxibutinina. Se describen una composición que incluye oxibutinina, un dispositivo que incluye oxibutinina, y un método para administrar oxibutinina, para terapia con oxibutinina.Oxybutynin therapy. A composition that includes oxybutynin, a device that includes oxybutynin, and a method for administering oxybutynin, for oxybutynin therapy are described.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/806,773 US5912268A (en) | 1995-05-22 | 1997-02-26 | Dosage form and method for treating incontinence |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2141044A1 ES2141044A1 (en) | 2000-03-01 |
ES2141044B1 true ES2141044B1 (en) | 2001-02-01 |
Family
ID=25194814
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES9800339A Expired - Fee Related ES2141044B1 (en) | 1997-02-26 | 1998-02-19 | OXIBUTININE THERAPY. |
Country Status (1)
Country | Link |
---|---|
ES (1) | ES2141044B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030185882A1 (en) * | 2001-11-06 | 2003-10-02 | Vergez Juan A. | Pharmaceutical compositions containing oxybutynin |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2665858B2 (en) * | 1992-05-30 | 1997-10-22 | 日本ヘキスト・マリオン・ルセル株式会社 | Long-acting oxybutynin hydrochloride preparation |
JP2646170B2 (en) * | 1992-06-24 | 1997-08-25 | 日本ヘキスト・マリオン・ルセル株式会社 | Sustained-release oxybutynin hydrochloride preparation |
US5399359A (en) * | 1994-03-04 | 1995-03-21 | Edward Mendell Co., Inc. | Controlled release oxybutynin formulations |
US5674895A (en) * | 1995-05-22 | 1997-10-07 | Alza Corporation | Dosage form comprising oxybutynin |
-
1998
- 1998-02-19 ES ES9800339A patent/ES2141044B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2141044A1 (en) | 2000-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2182906T3 (en) | HELICOIDAL SURGICAL STAPLE. | |
ES2172587T3 (en) | COMPOSITION THAT INCLUDES MORPHINE, POLYPIRROLIDONE AND ALKYLENE POLY-OXIDE. | |
ES2114487B1 (en) | SYNERGISTIC STABILIZING MIX. | |
GB2318055A (en) | Dosage form comprising oxybutynin | |
DK1037634T3 (en) | Oral administration comprising a proton pump inhibitor (e.g. pantoprazo) | |
DE60010098D1 (en) | 28-EPIRAPALOGE | |
MX9306499A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING AN AMPHETAMINE. | |
TR199501472A2 (en) | Matrix metalloprotease inhibitors. | |
EE04003B1 (en) | An oral pharmaceutical dosage form containing a proton pump inhibitor and an NSAID | |
EE9700195A (en) | An oral pharmaceutical dosage form comprising a proton pump inhibitor and a prokinetic agent | |
DK1036058T3 (en) | adamantane | |
DK1036059T3 (en) | adamantane | |
FI963515A (en) | A transdermal system in the form of a patch containing a tamoxifen derivative | |
ES2145373T3 (en) | PROCEDURE FOR THE DEVELOPMENT OF TRAMADOL RACEMATE. | |
ES2181168T3 (en) | SOLID BLENDS BASED ON SULFONILE AND ADJUSTERS. | |
ATE228760T1 (en) | THROMBIN INHIBITORS | |
ES2179529T3 (en) | BIAROMATIC COMPOUNDS UNITED BY A HETEROETYLLENE RADICAL, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM. | |
ES2141044B1 (en) | OXIBUTININE THERAPY. | |
AR018321A1 (en) | A DOSAGE FORM OF PROLONGED LIBERATION THAT INCLUDES OXIBUTININE AND THE USES OF OXIBUTININE AND THE DOSAGE FORM OF PROLONGED LIBERATION. | |
EA200000112A1 (en) | NEW COMPOSITION | |
ATE323493T1 (en) | CONTROLLED RELEASE OF ANTIDEPRESSANTS | |
AU9294698A (en) | Methods and compositions for enhanced wound healing | |
CO5170459A1 (en) | TRANSDERMAL THERAPY WITH LON-OL STROGEN AGONISTS-ANTAGONISTS, ADMINISTERED BY TRANSDERMAL MEDIA | |
EP0618232A3 (en) | Substance BS-3, an anti-oxidant for fats and an analgesic. | |
NO981320L (en) | Oral use of (+) - O-demethyltramadol as a pain reliever |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 20000301 Kind code of ref document: A1 Effective date: 20000301 |
|
FD2A | Announcement of lapse in spain |
Effective date: 20180525 |